Position in INVA
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$103,368,747
+$16,204,333 QoQ
Shares Held
4,436,427
+1.7% QoQ
Ownership
6.01%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 94.42224564948324.ToString("F0")%
Shared 3.8437914114218494.ToString("F0")%
None 1.7339629390949067.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. INVA ranks #12 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in INVA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $103,368,747 | 4,436,427 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $87,164,414 | 4,360,401 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $79,028,940 | 4,330,353 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $86,274,353 | 4,294,393 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $84,481,990 | 4,659,790 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $85,353,634 | 4,919,518 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $90,620,399 | 4,692,926 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $76,827,339 | 4,684,594 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $70,306,050 | 4,613,258 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $72,452,661 | 4,516,999 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $57,814,643 | 4,450,704 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $53,230,582 | 4,181,507 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $42,549,793 | 3,782,204 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $42,495,318 | 3,207,194 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $34,088,338 | 2,936,119 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $39,826,550 | 2,698,276 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $49,156,623 | 2,540,394 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $43,700,149 | 2,533,342 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $42,354,753 | 2,534,695 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $33,019,751 | 2,462,323 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $27,724,693 | 2,320,058 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $29,149,048 | 2,352,627 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $24,638,665 | 2,357,767 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $32,670,155 | 2,336,921 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $26,565,992 | 2,259,013 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||